Table 1.

Clinical data at the beginning of GnRH analog treatment (M0) and after 12 months of quarterly triptorelin 11.25 mg (M12).

	M0	M12
Bone age, years	9.8 ± 1.2	10.7 ± 1.1
Height, cm	132.7 ± 7.8	139.1 ± 8.6°
Height, SDS*	−0.4 ± 1.3	−0.3 ± 0.9
Growth velocity, cm/year	11.0 ± 4.9	4.9 ± 2.1°°
Predicted adult height, cm	156.3 ± 9.6	160.8 ± 6.5
Predicted adult Height, SDS	−0.7 ± 1.5	−0.2 ± 1.1
Body mass index, kg/m2	18.0 ± 2.5	18.6 ± 2.4
Body mass index, SDS	2.8 ± 2.7	2.7 ± 2.0
Midparental height, cm	161.0 ± 4.5
Midparental height, SDS	−0.2 ± 0.8

*SDS for bone age; °P < 0.02 versus M0; °°P < 0.001 versus M0.